Thawing System Market

The Global Thawing System Market is expected to reach USD 252.7 million, at a CAGR of 12.6%.

Factors driving the growth of this market include technologically advanced applications of thawing devices, expanding storage capacities of biorepositories, and increasing the use of thawed cells in the treatment of cancers and diabetes.

The thawing system market covers devices that are used to unfreeze and defrost biological samples such as blood and blood products, semen, ovum, embryos, and human tissues.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=185341188

Thawing System Market segmentation:

· based on the type

· based on sample type

· based on the end user

· based on regions

The Major Players Operating in the Thawing System Market:

Key players in the thawing system market include Helmer Scientific (US), Boekel Scientific (US), Sarstedt (Germany), Barkey (Germany), BioCision (US), Cardinal Health (US), Sartorius (Germany), GE Healthcare (US), Thermo Fisher Scientific (US), and CytoTherm (US).

The objectives of this study are as follows:

• To define, describe, and forecast the thawing system market on the basis of type, sample type, end user, and region
• To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)
• To identify the micro-markets with respect to drivers, restraints, industry-specific challenges, opportunities, and trends affecting the growth of the market

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=185341188

Thawing System Market by End User:

• Blood Banks & Transfusion Centers
• Hospitals & Diagnostic Laboratories
• Cord Blood & Stem Cell Banks
• Research & Academic Institutes

Geographical Detailed Analysis for Thawing System Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is estimated to dominate the thawing system market. This is attributed to factors such as improvements in blood bank and biobank infrastructure, increasing research activities in regenerative medicine as well as cell and gene therapy, growing interest in personalized medicine and biomarker discovery, increasing number of biotechnology and pharmaceutical companies, and increasing government funding.